Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...
Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...
Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide ...
Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives to overdoses of OxyContin and offshoots of the highly addictive painkiller.
Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback